Search by Drug Name or NDC

    NDC 00310-6210-95 FARXIGA 10 mg/1 Details

    FARXIGA 10 mg/1

    FARXIGA is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AstraZeneca Pharmaceuticals LP. The primary component is DAPAGLIFLOZIN PROPANEDIOL.

    Product Information

    NDC 00310-6210
    Product ID 0310-6210_ea201b5d-7770-4b38-9913-f044f38976dc
    Associated GPIs 27700040200320
    GCN Sequence Number 070755
    GCN Sequence Number Description dapagliflozin propanediol TABLET 10 MG ORAL
    HIC3 C4D
    HIC3 Description ANTIHYPERGLYCEMIC-SOD/GLUC COTRANSPORT2(SGLT2) INH
    GCN 34394
    HICL Sequence Number 040137
    HICL Sequence Number Description DAPAGLIFLOZIN PROPANEDIOL
    Brand/Generic Brand
    Proprietary Name FARXIGA
    Proprietary Name Suffix n/a
    Non-Proprietary Name DAPAGLIFLOZIN
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 10
    Active Ingredient Units mg/1
    Substance Name DAPAGLIFLOZIN PROPANEDIOL
    Labeler Name AstraZeneca Pharmaceuticals LP
    Pharmaceutical Class Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA202293
    Listing Certified Through 2025-12-31

    Package

    NDC 00310-6210-95 (00310621095)

    NDC Package Code 0310-6210-95
    Billing NDC 00310621095
    Package 1 BLISTER PACK in 1 CARTON (0310-6210-95) / 7 TABLET, FILM COATED in 1 BLISTER PACK
    Marketing Start Date 2015-01-05
    NDC Exclude Flag N
    Pricing Information N/A